Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Stephen Elledge
Johns Hopkins University, Department: Pathology
Should you be removed from our database? Contact us at [email protected]. Read more below.
TSCAN Therapeutics, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The research proposes to develop an inexpensive high through-put assay to screen for specific epitopes that is adaptable to a clinical setting. TSCAN Therapeutics, Inc., is focused on discovering the epitopes recognized by T cells in patients, and is licensing the T-SCAN technology used in this research. The use of the T-SCAN technology in this project would further demonstrate the technology’s application, thereby benefiting the company.
Development of Highly Multiplex Antigen Specificity Assays
There is a need for new technologies that extract more clinically actionable information from smaller patient samples; this need is particularly acute for tests of the immune system, due to its inherent complexity. This project builds upon our previous work, which integrates powerful technologies in synthetic biology and high throughput DNA sequencing, to develop sample sparing assays that comprehensively characterize the targets of an immune response. These assays will be useful to researchers and clinicians that study the epidemiology of infection, vaccine development, autoimmunity, and cancer immunotherapy.
Filed on January 24, 2019.
Tell us what you know about Stephen Elledge's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Stephen Elledge filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Stephen Elledge | Johns Hopkins University | Conflict of Interest | TSCAN Therapeutics, Inc. | $60,000 - $79,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.